Your browser doesn't support javascript.
loading
Safety and efficacy of CD22 and CD19 CAR-T bridging auto-HSCT as consolidation therapy for AYA and adult B-ALL.
Qiu, Yan; Wan, Chao-Ling; Xu, Ming-Zhu; Zhou, Hai-Xia; Liu, Mei-Jing; Gong, Wen-Jie; Kang, Li-Qing; Sun, Ai-Ning; Yu, Lei; Wu, De-Pei; Qian, Chong-Sheng; Xue, Sheng-Li.
Afiliación
  • Qiu Y; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
  • Wan CL; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, 215000, Suzhou, People's Republic of China.
  • Xu MZ; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
  • Zhou HX; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, 215000, Suzhou, People's Republic of China.
  • Liu MJ; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
  • Gong WJ; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, 215000, Suzhou, People's Republic of China.
  • Kang LQ; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
  • Sun AN; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, 215000, Suzhou, People's Republic of China.
  • Yu L; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
  • Wu DP; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, 215000, Suzhou, People's Republic of China.
  • Qian CS; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
  • Xue SL; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, 215000, Suzhou, People's Republic of China.
Blood Cancer J ; 13(1): 66, 2023 05 03.
Article en En | MEDLINE | ID: mdl-37137904
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma de Burkitt / Trasplante de Células Madre Hematopoyéticas / Receptores Quiméricos de Antígenos Límite: Adult / Humans Idioma: En Revista: Blood Cancer J Año: 2023 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma de Burkitt / Trasplante de Células Madre Hematopoyéticas / Receptores Quiméricos de Antígenos Límite: Adult / Humans Idioma: En Revista: Blood Cancer J Año: 2023 Tipo del documento: Article